Assessing the Potential Cost Effectiveness of Pneumococcal Vaccines in the US
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 15 (1) , 31-36
- https://doi.org/10.2165/00002512-199915001-00004
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Community-acquired pneumoniaThe Lancet, 1998
- Cost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly PeoplePublished by American Medical Association (AMA) ,1997
- Fortnightly Review: The pneumococcal problemBMJ, 1996
- Resistance to Penicillin and Cephalosporin and Mortality from Severe Pneumococcal Pneumonia in Barcelona, SpainNew England Journal of Medicine, 1995
- Comprehensiveness and bias in reporting clinical trials. Study of reviews of pneumococcal vaccine effectiveness.1995
- Efficacy of Pneumococcal Vaccination in AdultsArchives of internal medicine (1960), 1994
- Pneumococcal vaccine. Efficacy and associated cost savingsJAMA, 1990
- Mortality from acute respiratory infections in children under 5 years of age: global estimates.1986
- Cost Effectiveness of Vaccination Against Pneumococcal Pneumonia: An UpdateAnnals of Internal Medicine, 1986
- Cost Effectiveness of Vaccination against Pneumococcal PneumoniaNew England Journal of Medicine, 1980